Bizcommunity1h
Herbicide-resistant weeds threaten profitable soya bean production
Herbicide-resistant weeds challenge producers and agrochemical companies with a vexing issue that some refer to as a ‘wicked ...
Protein 'seeds' trigger key pathological features of ALS and frontotemporal dementia
Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a study published in Neuron, ...
Technology Networks3d
New Model Mimics TDP-43 Aggregation in ALS and Frontotemporal Dementia
Researchers have developed a laboratory model that mimics the pathological aggregation of TDP-43, a key protein in ALS and ...
Mitsubishi Tanabe Pharma America Announces Publication of Preclinical Research on the Role of Edaravone in Mitigating TDP-43 Mislocalization in ALS
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of new preclinical research in Free Radical Biology and Medicine, highlighting the role of edaravone in mitigating TDP-43 ...
News-Medical.Net on MSN2d
Scientists develop lab model to study TDP-43 accumulation in neurodegeneration
Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a newly published study, ...
How cells respond to stress is more nuanced than previously believed
The body's cells respond to stress—toxins, mutations, starvation or other assaults—by pausing normal functions to focus on ...
Pharmabiz4d
SineuGene Therapeutics receives US FDA’s investigational new drug application clearance for SNUG01 to treat amyotrophic lateral sclerosis
SineuGene Therapeutics receives US FDA’s investigational new drug application clearance for SNUG01 to treat amyotrophic lateral sclerosis: Beijing Thursday, March 27, 2025, 15:0 ...
The Manila Times6d
SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72-Targeted Gene Therapy for ALS
SineuGene Therapeutics Co., Ltd. ('SineuGene'), a clinical-stage biotech company pioneering innovative therapies for neurological disorders, today announced that the U.S. Food and Drug Administration ...